On Tuesday, HCA Healthcare Inc (NYSE: HCA) opened higher 1.33% from the last session, before settling in for the closing price of $363.28. Price fluctuations for HCA have ranged from $289.98 to $417.14 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 6.69% annually for the last half of the decade. Company’s average yearly earnings per share was noted 15.08% at the time writing. With a float of $170.51 million, this company’s outstanding shares have now reached $242.96 million.
In an organization with 316000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 67.91%, operating margin of 15.15%, and the pretax margin is 12.02%.
HCA Healthcare Inc (HCA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of HCA Healthcare Inc is 29.12%, while institutional ownership is 68.19%. The most recent insider transaction that took place on May 13 ’25, was worth 5,797,660. Before that another transaction happened on Feb 14 ’25, when Company’s SVP & Chief Human Res. Officer sold 9,533 for $322.59, making the entire transaction worth $3,075,240. This insider now owns 15,412 shares in total.
HCA Healthcare Inc (HCA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 5.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.92% during the next five years compared to 16.93% growth over the previous five years of trading.
HCA Healthcare Inc (NYSE: HCA) Trading Performance Indicators
Check out the current performance indicators for HCA Healthcare Inc (HCA). In the past quarter, the stock posted a quick ratio of 1.06. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.24. Likewise, its price to free cash flow for the trailing twelve months is 17.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 22.51, a number that is poised to hit 6.24 in the next quarter and is forecasted to reach 27.99 in one year’s time.
Technical Analysis of HCA Healthcare Inc (HCA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.61 million. That was inferior than the volume of 1.66 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 75.80%. Additionally, its Average True Range was 11.44.
During the past 100 days, HCA Healthcare Inc’s (HCA) raw stochastic average was set at 93.68%, which indicates a significant increase from 89.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.73% in the past 14 days, which was lower than the 32.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $336.60, while its 200-day Moving Average is $347.53. However, in the short run, HCA Healthcare Inc’s stock first resistance to watch stands at $373.54. Second resistance stands at $378.98. The third major resistance level sits at $385.02. If the price goes on to break the first support level at $362.06, it is likely to go to the next support level at $356.01. The third support level lies at $350.57 if the price breaches the second support level.
HCA Healthcare Inc (NYSE: HCA) Key Stats
There are currently 240,574K shares outstanding in the company with a market cap of 88.56 billion. Presently, the company’s annual sales total 70,603 M according to its annual income of 5,760 M. Last quarter, the company’s sales amounted to 18,321 M and its income totaled 1,610 M.
